semaglutide nature medicine Modulation of metabolic, inflammatory and fibrotic pathways by in metabolic dysfunction-associated steatohepatitis Obesity drugs: huge study identifies

R.KitchingA

Europe held the second-largest market share of 23% in 2025, due to the prevalence of diabetes and obesity in the region, established healthcare systems that ensure wide prescription of medication, and a regulatory framework that makes the approval and reimbursement of GLP-1 drugs easier

It also has a large warehouse capable of storing at least nine months of raw pharmaceutical ingredients to minimise supply chain deficiencies that could interfere with patient care

They outline how recent enforcement actions signal a shift toward stricter oversight of telehealth providers and compounding pharmacies and what these developments may mean for the future of the industry and its compliance strategies

Regulatory authorities require extensive long-term safety data before licensing decisions are made